Literature DB >> 27058823

CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis.

Jian Zheng1, Xiaobai Liu1, Ping Wang2, Yixue Xue2, Jun Ma2, Chengbin Qu1, Yunhui Liu3.   

Abstract

Colorectal neoplasia differentially expressed (CRNDE) is the most upregulated long noncoding RNA (lncRNA) in glioma. Herein, the function and potential molecular mechanisms of CRNDE and miR-384 were illustrated in glioma cells. CRNDE overexpression facilitated cell proliferation, migration, and invasion, while inhibited glioma cells apoptosis. Quantitative real-time polymerase chain reaction (PCR) demonstrated that miR-384 was downregulated in human glioma tissues and glioma cell lines. Moreover, restoration of miR-384 exerted tumor-suppressive functions. In addition, the expression of miR-384 was negatively correlated with CRNDE expression. A binding region between CRNDE and miR-384 was confirmed using luciferase assays. Moreover, CRNDE promoted cell malignant behavior by decreasing miR-384 expression. At the molecular level, treatment by CRNDE knockdown or miR-384 overexpression resulted in a decrease of piwi-like RNA-mediated gene silencing 4 (PIWIL4) protein. Besides, PIWIL4 was identified as a target of miR-384 and plays an oncogenic role in glioma. Similarly, downstream proteins of PIWIL4 such as STAT3, cyclin D1, VEGFA, SLUG, MMP-9, caspase 3, Bcl-2, and bcl-xL were modulated when treated with miR-384 and PIWIL4. Remarkably, CRNDE knockdown combined with miR-384 overexpression led to tumor regression in vivo. Overall, these results depicted a novel pathway mediated by CRNDE in glioma, which may be a potential application for glioma therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27058823      PMCID: PMC5088760          DOI: 10.1038/mt.2016.71

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  61 in total

Review 1.  lncRNAs and microRNAs with a role in cancer development.

Authors:  Julia Liz; Manel Esteller
Journal:  Biochim Biophys Acta       Date:  2015-07-04

2.  Overexpression of PIWI proteins in human stage III epithelial ovarian cancer with lymph node metastasis.

Authors:  Chao Chen; Jianhua Liu; Guoxiong Xu
Journal:  Cancer Biomark       Date:  2013       Impact factor: 4.388

Review 3.  Caspase-3 and prostaglandins signal for tumor regrowth in cancer therapy.

Authors:  L Galluzzi; O Kepp; G Kroemer
Journal:  Oncogene       Date:  2011-10-03       Impact factor: 9.867

4.  Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation.

Authors:  Pengjun Wang; Zhongqiao Ren; Piyun Sun
Journal:  J Cell Biochem       Date:  2012-06       Impact factor: 4.429

5.  A tubulin binding peptide targets glioma cells disrupting their microtubules, blocking migration, and inducing apoptosis.

Authors:  Raphael Berges; Julien Balzeau; Alan C Peterson; Joel Eyer
Journal:  Mol Ther       Date:  2012-04-10       Impact factor: 11.454

6.  Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy.

Authors:  Alan McIntyre; Shalini Patiar; Simon Wigfield; Ji-Liang Li; Ioanna Ledaki; Helen Turley; Russell Leek; Cameron Snell; Kevin Gatter; William S Sly; Richard D Vaughan-Jones; Pawel Swietach; Adrian L Harris
Journal:  Clin Cancer Res       Date:  2012-04-12       Impact factor: 12.531

7.  Combined inhibition of MEK and mammalian target of rapamycin abolishes phosphorylation of cyclin-dependent kinase 4 in glioblastoma cell lines and prevents their proliferation.

Authors:  Sabine Paternot; Pierre P Roger
Journal:  Cancer Res       Date:  2009-05-19       Impact factor: 12.701

8.  KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.

Authors:  Kyung-Hwa Lee; Eun-Jung Ahn; Se-Jeong Oh; Ok Kim; Young-Eun Joo; Jeong-A Bae; Somy Yoon; Hyang-Hwa Ryu; Shin Jung; Kyung-Keun Kim; Jae-Hyuk Lee; Kyung-Sub Moon
Journal:  Oncotarget       Date:  2015-02-20

9.  MicroRNA-27b suppresses tumor progression by regulating ARFGEF1 and focal adhesion signaling.

Authors:  Rei Matsuyama; Daisuke Okuzaki; Masato Okada; Chitose Oneyama
Journal:  Cancer Sci       Date:  2015-11-18       Impact factor: 6.716

10.  Negative regulation of signal transducer and activator of transcription-3 signalling cascade by lupeol inhibits growth and induces apoptosis in hepatocellular carcinoma cells.

Authors:  K S Siveen; A H Nguyen; J H Lee; F Li; S S Singh; A P Kumar; G Low; S Jha; V Tergaonkar; K S Ahn; G Sethi
Journal:  Br J Cancer       Date:  2014-08-07       Impact factor: 7.640

View more
  91 in total

Review 1.  CRNDE: An important oncogenic long non-coding RNA in human cancers.

Authors:  Jiaming Zhang; Minuo Yin; Gang Peng; Yingchao Zhao
Journal:  Cell Prolif       Date:  2018-02-05       Impact factor: 6.831

2.  Long non-coding RNA CRNDE sponges miR-384 to promote proliferation and metastasis of pancreatic cancer cells through upregulating IRS1.

Authors:  Gang Wang; Jingen Pan; Lu Zhang; Yajun Wei; Cheng Wang
Journal:  Cell Prolif       Date:  2017-09-21       Impact factor: 6.831

3.  lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5.

Authors:  Peng Gu; Xu Chen; Ruihui Xie; Jinli Han; Weibin Xie; Bo Wang; Wen Dong; Changhao Chen; Meihua Yang; Junyi Jiang; Ziyue Chen; Jian Huang; Tianxin Lin
Journal:  Mol Ther       Date:  2017-05-06       Impact factor: 11.454

4.  LncRNA CRNDE regulates trophoblast cell proliferation, invasion, and migration via modulating miR-1277.

Authors:  Hua Zhu; Li Kong
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

5.  miR-423-5p inhibits the proliferation and metastasis of glioblastoma cells by targeting phospholipase C beta 1.

Authors:  Peng Zhao; Shukai Sun; Yu'e Zhai; Qingwu Tian; Tingting Zhou; Jing Li
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

6.  CRNDE Expression Positively Correlates with EGFR Activation and Modulates Glioma Cell Growth.

Authors:  Karrie Mei-Yee Kiang; Xiao-Qin Zhang; Grace Pingde Zhang; Ning Li; Stephen Yin Cheng; Ming-Wai Poon; Jenny Kan-Suen Pu; Wai-Man Lui; Gilberto Ka-Kit Leung
Journal:  Target Oncol       Date:  2017-06       Impact factor: 4.493

Review 7.  Novel insights into the interaction between long non-coding RNAs and microRNAs in glioma.

Authors:  Anahita Ebrahimpour; Mohammad Sarfi; Setareh Rezatabar; Sadra Samavarchi Tehrani
Journal:  Mol Cell Biochem       Date:  2021-02-13       Impact factor: 3.396

8.  The Effect and Mechanism of LINC00663 on the Biological Behavior of Glioma.

Authors:  Meichen Pan; Jingren Shi; Shangqi Yin; Huan Meng; Chaonan He; Yajie Wang
Journal:  Neurochem Res       Date:  2021-04-08       Impact factor: 3.996

Review 9.  LncRNA-ATB: An indispensable cancer-related long noncoding RNA.

Authors:  Jinglin Li; Zhenglong Li; Wangyang Zheng; Xinheng Li; Zhidong Wang; Yunfu Cui; Xingming Jiang
Journal:  Cell Prolif       Date:  2017-09-08       Impact factor: 6.831

10.  The long non-coding RNA CRNDE competed endogenously with miR-205 to promote proliferation and metastasis of melanoma cells by targeting CCL18.

Authors:  Libin Xu; Yu Zhang; Zhenguo Zhao; Zhengju Chen; Zheng Wang; Songfeng Xu; Xinxin Zhang; Ting Liu; Shengji Yu
Journal:  Cell Cycle       Date:  2018-10-09       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.